These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38416235)

  • 1. Clinical features of double seronegative ocular myasthenia gravis.
    Goto T; Kimura A; Masuda A; Mochizuki Y; Gomi F
    Graefes Arch Clin Exp Ophthalmol; 2024 Aug; 262(8):2617-2623. PubMed ID: 38416235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular myasthenia gravis in an academic neuro-ophthalmology clinic: clinical features and therapeutic response.
    Mittal MK; Barohn RJ; Pasnoor M; McVey A; Herbelin L; Whittaker T; Dimachkie M
    J Clin Neuromuscul Dis; 2011 Sep; 13(1):46-52. PubMed ID: 22361625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with insensitivity to pyridostigmine therapy in Thai patients with ocular myasthenia gravis.
    Chirapapaisan N; Tanormrod S; Chuenkongkaew W
    Asian Pac J Allergy Immunol; 2007 Mar; 25(1):13-6. PubMed ID: 17891917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular motor dysfunction and ptosis in ocular myasthenia gravis: effects of treatment.
    Kupersmith MJ; Ying G
    Br J Ophthalmol; 2005 Oct; 89(10):1330-4. PubMed ID: 16170126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cigarette Smoking and Activities of Daily Living in Ocular Myasthenia Gravis.
    Gratton SM; Herro AM; Feuer WJ; Lam BL
    J Neuroophthalmol; 2016 Mar; 36(1):37-40. PubMed ID: 26457691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical profiles of Thai patients with ocular myasthenia gravis in Siriraj Hospital.
    Leeamornsiri S; Chirapapaisan N; Chuenkongkaew W
    J Med Assoc Thai; 2011 Sep; 94(9):1117-21. PubMed ID: 21970202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic yields and clinical features of ocular myasthenia gravis.
    Kim H; Oh SY
    Medicine (Baltimore); 2021 Jun; 100(25):e26457. PubMed ID: 34160444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric Autoimmune Ocular Myasthenia Gravis: Evaluation of Presentation and Treatment Outcomes in a Large Cohort.
    Fisher KS; Gill J; Todd HF; Yang MB; Lopez MA; Abid F; Lotze T; Shah VS
    Pediatr Neurol; 2021 May; 118():12-19. PubMed ID: 33684630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcomes of pediatric ocular myasthenia gravis.
    Ortiz S; Borchert M
    Ophthalmology; 2008 Jul; 115(7):1245-1248.e1. PubMed ID: 18155768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Childhood myasthenia gravis: clinical features and outcomes.
    Sri-udomkajorn S; Panichai P; Liumsuwan S
    J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S152-7. PubMed ID: 22043769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric Ocular Myasthenia Gravis: Single-Center Experience.
    Kessi M; Tang Y; Chen B; Wang G; Zhang C; He F; Peng J; Yin F; Yang L
    Pediatr Neurol; 2024 Apr; 153():137-143. PubMed ID: 38382246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visual and systemic outcomes in pediatric ocular myasthenia gravis.
    Pineles SL; Avery RA; Moss HE; Finkel R; Blinman T; Kaiser L; Liu GT
    Am J Ophthalmol; 2010 Oct; 150(4):453-459.e3. PubMed ID: 20678749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of prednisone on the progression from ocular to generalized myasthenia gravis.
    Monsul NT; Patwa HS; Knorr AM; Lesser RL; Goldstein JM
    J Neurol Sci; 2004 Feb; 217(2):131-3. PubMed ID: 14706214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to treatment in pediatric ocular myasthenia gravis.
    Xu L; Castro D; Reisch JS; Iannaccone ST
    Muscle Nerve; 2020 Feb; 61(2):226-230. PubMed ID: 31650555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there still a role for edrophonium in diagnosing ocular myasthenia.
    Karatas H; Nurlu G; Kansu T
    Eur J Neurol; 2007 Mar; 14(3):e4-5. PubMed ID: 17355538
    [No Abstract]   [Full Text] [Related]  

  • 16. Ocular myasthenia gravis: treatment successes and failures in patients with long-term follow-up.
    Kupersmith MJ
    J Neurol; 2009 Aug; 256(8):1314-20. PubMed ID: 19377863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The natural history and ophthalmic involvement in childhood myasthenia gravis at the hospital for sick children.
    Mullaney P; Vajsar J; Smith R; Buncic JR
    Ophthalmology; 2000 Mar; 107(3):504-10. PubMed ID: 10711889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Oculomotor disorders due to general causes].
    Vlăduţiu C; Macarie S; Demea S; Călugăru M
    Oftalmologia; 1998; 45(4):23-7. PubMed ID: 10418624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular aspects of myasthenia gravis.
    Barton JJ; Fouladvand M
    Semin Neurol; 2000; 20(1):7-20. PubMed ID: 10874773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ocular myasthenia gravis: diagnostic aspects and evolution].
    de Entrambasaguas M; López-Bernabé R; López-Alemany M
    Rev Neurol; 2007 Apr 1-15; 44(7):397-403. PubMed ID: 17420965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.